Astec Lifesciences (NSE:ASTEC) Moat Score: 0/10 (As of Jul. 02, 2026)


NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
74 GF Score
Price ₹713.65
GF Value ₹982.45
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Astec Lifesciences Moat Score?

Astec Lifesciences has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Astec Lifesciences has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Astec Lifesciences might have No Moat - No discernible moat.

Astec Lifesciences  (NSE:ASTEC) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Astec Lifesciences Moat Score Related Terms

NSE:ASTEC
74GF Score
Astec Lifesciences Ltd NSE:ASTEC
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹713.65 is trading 27.4% below its estimated GF Value™ of ₹982.45. GuruFocus considers Astec Lifesciences to be Modestly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Moat Score: 0
  • GF Value™: ₹982.45 vs. price of ₹713.65 (27.4% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
74GF Score

Get the complete analysis for NSE:ASTEC

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹713.65
Price
₹982.45
GF Value